Bajaj Healthcare Ltd Stock Price Today (NSE: BAJAJHCARE)
Fundamental Score
Bajaj Healthcare Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Bajaj Healthcare Ltd share price today is ₹299.20, down 1.03% on NSE/BSE as of 17 June 2026. Bajaj Healthcare Ltd (BAJAJHCARE) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹1.35K (Cr). The 52-week high for BAJAJHCARE share price is ₹N/A and the 52-week low is ₹272.35. At a P/E ratio of 26.45x, BAJAJHCARE is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 10.69% and a debt-to-equity ratio of 0.49.
Bajaj Healthcare Ltd Share Price Chart — NSE/BSE Historical Performance
Bajaj Healthcare Ltd share price chart: -8.56% return over the past month. 52-week high ₹N/A, 52-week low ₹272.35.
Bajaj Healthcare Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹295.00 | ₹303.30 | ₹292.70 | ₹299.80 | 81.28K (Cr) | |
| ₹306.75 | ₹308.95 | ₹290.40 | ₹294.00 | 2.98L (Cr) | |
| ₹310.00 | ₹313.80 | ₹301.00 | ₹302.20 | 1.22L (Cr) | |
| ₹307.05 | ₹307.05 | ₹307.05 | ₹307.05 | 0.00 (Cr) | |
| ₹308.00 | ₹314.90 | ₹302.65 | ₹307.05 | 2.17L (Cr) | |
| ₹302.30 | ₹308.65 | ₹299.60 | ₹305.25 | 1.03L (Cr) | |
| ₹305.55 | ₹310.40 | ₹301.10 | ₹302.50 | 87.89K (Cr) | |
| ₹305.95 | ₹308.00 | ₹300.60 | ₹305.55 | 75.71K (Cr) | |
| ₹303.50 | ₹307.50 | ₹297.45 | ₹304.45 | 1.99L (Cr) | |
| ₹288.00 | ₹303.00 | ₹284.00 | ₹298.70 | 1.44L (Cr) |
Bajaj Healthcare Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹306.75 | ₹308.95 | ₹290.40 | ₹299.80 | -2.27% | |
| ₹322.80 | ₹348.00 | ₹272.35 | ₹302.20 | -6.38% | |
| ₹303.20 | ₹0.00 | ₹0.00 | ₹321.75 | +6.12% | |
| ₹319.30 | ₹328.00 | ₹273.25 | ₹290.10 | -9.15% | |
| ₹341.00 | ₹386.45 | ₹328.00 | ₹329.65 | -3.33% | |
| ₹422.90 | ₹430.00 | ₹330.65 | ₹346.05 | -18.17% | |
| ₹432.50 | ₹436.50 | ₹393.45 | ₹415.10 | -4.02% | |
| ₹475.10 | ₹481.80 | ₹419.25 | ₹432.45 | -8.98% | |
| ₹489.90 | ₹506.45 | ₹445.70 | ₹475.55 | -2.93% | |
| ₹422.90 | ₹515.90 | ₹418.95 | ₹485.80 | +14.87% | |
| ₹489.00 | ₹489.70 | ₹420.00 | ₹421.75 | -13.75% | |
| ₹500.00 | ₹552.60 | ₹465.00 | ₹486.55 | -2.69% |
AI Research Briefing
Powered by Gemini · 2026-04-15
High-risk micro-cap API player; needs flawless CDMO execution to justify current valuation, otherwise, it's a zero.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Bajaj Healthcare's investment rating was upgraded from Strong Sell to Sell on April 10, 2026, due to improvements in technical indicators, although fundamental challenges persist. 63% increase from the previous close. The company also announced the closure of its trading window from April 1, 2026, until 48 hours after the release of FY26 results, in compliance with SEBI regulations.
CORE STORY (THE REAL GAME)
Bajaj Healthcare is a small-cap API and formulations player attempting to transition to a higher-margin CDMO and regulated market supplier. The market is focused on whether they can execute this shift amidst existing debt and working capital constraints.
- Technical rebound offering short-term trading opportunities
- Strong Q3FY26 results showing revenue and profit growth
- Potential for CDMO transition to drive higher margins
- Significant new CDMO contract wins
- Breakthrough regulatory approvals for key APIs
- Consistent earnings growth exceeding market expectations
- Micro-cap liquidity risk
- High Debt to EBITDA ratio of 2.80x
- Declining operating profit CAGR of -9.00% over the past five years
FII holdings slightly increased by 0.03%, while DII holdings decreased by 0.17%, indicating mixed institutional sentiment.
India Pharma 2026 emphasizes the need for enhanced funding, infrastructure, and faster execution to drive pharmaceutical innovation.
Poor, with a Free Cash Flow 5Y of ₹-175.36 Cr.
Next 3-6 months hinge on CDMO execution and regulatory approvals. Failure to deliver will lead to a re-rating.
Primary Thesis Risk
Inability to execute CDMO transition and manage debt will lead to collapse.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Bajaj Healthcare Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Bajaj Healthcare Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of BAJAJHCARE across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Strong Operating Margins (17.53%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Robust Profit Growth (49.28%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Balanced Promoter Holding (59.19%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Negative Free Cash Flow (₹-175.36 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 4.11%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Bajaj Healthcare Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Bajaj Healthcare Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Bajaj Healthcare LtdBajaj Healthcar...Selected✓ BAJAJHCARE • 539872 | 46.1/100 | ₹299.20₹299 | ₹1353.87₹1353.87 | 26.45Average 26.4 Average | 10.69%Average 10.69% Average | 11.44%Average 11.44% Average | 0.49Excellent 0.5 Excellent | 9.56%Good 9.56% Good | 5.76%Good 5.76% Good | 0.23% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1782.20₹1782 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6623.00₹6623 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4420.90₹4421 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1401.30₹1401 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1278.20₹1278 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2267.70₹2268 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹1089.00₹1089 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2336.10₹2336 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1462.30₹1462 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5251.50₹5252 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
Bajaj Healthcare Ltd PE Ratio History
Historical price-to-earnings ratio for BAJAJHCARE — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹13.12 | ₹415.10 | 31.6x |
| FY 2023 | ₹15.59 | ₹376.00 | 24.1x |
| FY 2022 | ₹25.87 | ₹444.60 | 17.2x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Bajaj Healthcare Ltd Dividend History
Annual cash dividends paid by BAJAJHCARE — dividend yield 0.23%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹2.76 Cr |
| FY 2024 | ₹2.76 Cr |
| FY 2023 | ₹4.14 Cr |
| FY 2022 | ₹1.38 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Bajaj Healthcare Ltd Quarterly Performance
Latest quarterly metrics for BAJAJHCARE — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
11.14%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
49.28%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
5.76%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
9.56%
Compounded annual net profit growth over 5 years
Bajaj Healthcare Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for BAJAJHCARE — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Bajaj Healthcare Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Bajaj Healthcare Ltd (BAJAJHCARE) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Bajaj Healthcare Ltd
About BAJAJHCARE (Bajaj Healthcare Ltd)
Bajaj Healthcare Ltd (BAJAJHCARE) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a... current market capitalisation of ₹1.35K (Cr). Bajaj Healthcare Ltd has delivered a Return on Equity (ROE) of 10.69% and a ROCE of 11.44%. The debt-to-equity ratio stands at 0.49, reflecting the company's capital structure. Investors tracking BAJAJHCARE share price can monitor key metrics including P/E ratio, promoter holding of 59.19%, and quarterly earnings growth.
Company Details
Key Leadership
Corporate Events
BAJAJHCARE Share Price: Frequently Asked Questions
What is the current share price of Bajaj Healthcare Ltd?
Bajaj Healthcare Ltd (BAJAJHCARE) trades at ₹299.20 on NSE and BSE. Market cap ₹1.35K (Cr). Educational data only.
What is the P/E ratio of Bajaj Healthcare Ltd?
Bajaj Healthcare Ltd has a P/E of 26.45x vs industry average 31.77x.
What is the Bull Run score for Bajaj Healthcare Ltd?
Bajaj Healthcare Ltd has a Bull Run score of 46.1/100 based on 25+ financial parameters.
Does Bajaj Healthcare Ltd pay dividends?
Bajaj Healthcare Ltd has a dividend yield of 0.23%. Past dividends don't guarantee future payments.
What is the ROE of Bajaj Healthcare Ltd?
Bajaj Healthcare Ltd has ROE of 10.69%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Bajaj Healthcare Ltd?
Bajaj Healthcare Ltd has debt-to-equity of 0.49.
Is Bajaj Healthcare Ltd a good investment?
Bull Run gives Bajaj Healthcare Ltd a score of 46.1/100. This is not investment advice — consult a SEBI-registered advisor.